On the importance of exposure variability to the doses of volatile organic compounds

Toxicological Sciences

Volumn 83, Issue 2, 2005, Pages 224-236

  Rappaport, S M ^a   Kupper, L L ^a   Lin, Y S ^a  

^a IL   (United States)

Author keywords

Acrylonitrile; Benzene; Perchloroethylene; Variation of exposure; Volatile organic compounds

Indexed keywords

ACRYLONITRILE; BENZENE; CARCINOGEN; TETRACHLOROETHYLENE; VOLATILE ORGANIC COMPOUND;

AREA UNDER THE CURVE; ARTICLE; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; DOSE RESPONSE; LINEAR SYSTEM; LIVER CARCINOGENESIS; MATHEMATICAL COMPUTING; METABOLIC RATE; METABOLITE; NONLINEAR SYSTEM; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PREDICTION; SENSITIVITY ANALYSIS; SIMULATION; TOXICOKINETICS;

ACRYLONITRILE; AIR POLLUTANTS, OCCUPATIONAL; AREA UNDER CURVE; BENZENE; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; INHALATION EXPOSURE; MODELS, BIOLOGICAL; OCCUPATIONAL EXPOSURE; TETRACHLOROETHYLENE;

CACTUS VIRUS X;

EID: 13644262825     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfi039     Document Type: Article

References (37)

1. ACGIH (2004). 2004 Threshold Limit Values and Biological Exposure Indices for Chemical Substances and Physical Agents. American Conference of Governmental Industrial Hygienists, Cincinnati, Ohio.
2. Andersen, M. E. (1981a). A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: Analysis at steady state. Toxicol. Appl. Pharmacol. 60, 509-526.
3. Andersen, M. E. (1981b). Saturable metabolism and its relationship to toxicity. Crit. Rev. Toxicol. 9, 105-150.
4. Clewell, H. J., 3rd, Andersen, M. E., and Barton, H. A. (2002). A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Environ. Health Perspect. 110, 85-93.
5. Collins, J. J., Ireland, B., Buckley, C. F., and Shepperly, D. (2003). Lymphohaematopoeitic cancer mortality among workers with benzene exposure. Occup. Environ. Med. 60, 676-679.
6. Collins, J. J., and Strother, D. E. (1999). CNS tumors and exposure to acrylonitrile: Inconsistency between experimental and epidemiology studies. Neuro-oncol. 1, 221-230.
7. Cox, L. A., Jr. (1995). Simple relations between administered and internal doses in compartmental flow models. Risk Anal. 15, 197-204.
8. Dobrev, I. D., Andersen, M. E., and Yang, R. S. (2001). Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling. Arch. Toxicol. 75, 134-144.
9. Dobrev, I. D., Andersen, M. E., and Yang, R. S. (2002). In silico toxicology: Simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane. Environ. Health Perspect. 110, 1031-1039.
10. Droz, P. O., and Guillemin, M. P. (1983). Human styrene exposure. V. Development of a model for biological monitoring. Int. Arch. Occup. Environ. Health 53, 19-36.
11. Gallo, M. A. (2001). History and Scope of Toxicology. In Casarett and Doull's Toxicology, 6th edition (C.D.K. Klaasson, Ed.). McGraw-Hill, New York.
12. Glass, D. C., Gray, C. N., Jolley, D. J., Gibbons, C., Sim, M. R., Fritschi, L., Adams, G. G., Bisby, J. A., and Manuell, R. (2003). Leukemia risk associated with low-level benzene exposure. Epidemiology 14, 569-577.
13. Hayes, R. B., Yin, S. N., Dosemeci, M., Li, G. L., Wacholder, S., Chow, W. H., Rothman, N., Wang, Y. Z., Dai, T. R., Chao, X. J., et al. (1996). Mortality among benzene-exposed workers in China. Environ. Health Perspect. 104, 1349-1352.
14. Hayes, R. B., Yin, S. N., Dosemeci, M., Li, G. L., Wacholder, S., Travis, L. B., Li, C. Y., Rothman, N., Hoover, R. N., and Linet, M. S. (1997). Benzene and the dose-related incidence of hematologic neoplasms in China - Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. J. Natl. Cancer Inst. 89, 1065-1071.
15. Kirman, C. R., Hays, S. M., Kedderis, G. L., Gargas, M. L., and Strother, D. E. (2000). Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: An analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the rat. Risk Anal. 20, 135-151.
16. Kromhout, H., Symanski, E., and Rappaport, S. M. (1993). A comprehensive evaluation of within- and between-worker components of occupational exposure to chemical agents. Ann. Occup. Hyg. 37, 253-270.
17. Kumagai, S., and Matsunaga, I. (1995). Effect of variation of exposure to airborne chlorobenzene on internal exposure and concentrations of urinary metabolite. Occup. Environ. Med. 52, 65-70.
18. Lash, L. H., and Parker, J. C. (200 1). Hepatic and renal toxicities associated with perchloroethylene. Pharmacol. Rev. 53, 177-208.
19. Olson, W. H., and Cumming, R. B. (1981). Chemical mutagens: Dosimetry. Haber's rule and linear systems. J. Theor. Biol. 91, 383-395.
20. Ramsey, J. C., and Andersen, M. E. (1984). A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73, 159-175.
21. Rappaport, S. M. (1985). Smoothing of exposure variability at the receptor: Implications for health standards. Ann. Occup. Hyg. 29, 201-214.
22. Rappaport, S. M. (1991). Assessment of long-term exposures to toxic substances in air. Ann. Occup. Hyg. 35, 61-121.
23. Rappaport, S. M., and Kupper, L. L. (2004). Variability of environmental exposures to volatile organic compounds. J. Expo. Anal. Environ. Epidemiol. 14, 92-107.
24. Rappaport, S. M., Lyles, R. H., and Kupper, L. L. (1995). An exposure assessment strategy accounting for within- and between- worker sources of variability. Ann. Occup. Hyg. 39, 469-495.
25. Rappaport, S. M., Waidyanatha, S., Qu, Q., Shore, R., Jin, X., Cohen, B., Chen, L. C., Melikian, A. A., Li, G., Yin, S., et al. (2002a). Albumin adducts of benzene oxide and 1,4-benzoquinone as measures of human benzene metabolism. Cancer Res. 62, 1330-1337.
26. Rappaport, S. M., Yeowell-O'Connell, K., Smith, M. T., Dosemeci, M., Hayes, R. B., Zhang, L., Li, G., Yin, S., and Rothman, N. (2002b). Non-linear production of benzene oxide-albuntin adducts with human exposure to benzene. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 778, 367-374.
27. Roach, S. A. (1966). A more rational basis for air-sampling programs. Am. Ind. Hyg. Assoc. J. 27, 1-12.
28. Roach, S. A. (1977). A most rational basis for air sampling programmes. Ann. Occup. Hyg. 20, 65-84.
29. Savitz, D. A., and Andrews, K. W. (1996). Risk of myelogenous leukaemia and multiple myeloma in workers exposed to benzene. Occup. Environ. Med. 53, 357-358.
30. Savitz, D. A., and Andrews, K. W. (1997). Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am. J. Ind. Med. 31, 287-295.
31. Smith, T. (1992). Occupational exposure and dose over time: Limitations of cumulative exposure. Am. J. Ind. Med. 21, 35-51.
32. Smith, T. J. (1987). Exposure assessment for occupational epidemiology. Am. J. Ind. Med. 12, 249-268.
33. Snyder, R. (2002). Benzene and leukemia. Crit. Rev. Toxicol. 32, 155-210.
34. Sweeney, L. M., Gargas, M. L., Strother, D. E., and Kedderis, G. L. (2003). Physiologically based pharmacokinetic model parameter estimation and sensitivity and variability analyses for acrylonitrile disposition in humans. Toxicol. Sci. 71, 27-40.
35. Tardif, R., Droz, P. O., Charest-Tardif, G., Pierrehumbert, G., and Truchon, G. (2002). Impact of human variability on the biological monitoring of exposure to toluene: I. Physiologically based toxicokinetic modelling. Toxicol. Lett. 134, 155-163.
36. Travis, C. C., Quillen, J. L., and Arms, A. D. (1990). Pharmacokinetics of benzene. Toxicol. Appl. Pharmacol. 102, 400-420.
37. Waidyanatha, S., Rothman, N., Li, G., Smith, M. T., Yin, S., and Rappaport, S. M. (2004). Rapid determination of six urinary benzene metabolites in occupationally exposed and unexposed subjects. Anal. Biochem. 327, 184-199.